temoporfin has been researched along with Carcinoma, Epidermoid in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (31.03) | 18.2507 |
2000's | 22 (37.93) | 29.6817 |
2010's | 17 (29.31) | 24.3611 |
2020's | 1 (1.72) | 2.80 |
Authors | Studies |
---|---|
Hamdoon, Z; Hopper, C; Jerjes, W; Yousif, AA | 1 |
Hamdoon, Z; Hopper, C; Jerjes, W | 1 |
Choudhary, MG; Gadbail, AR; Gondivkar, SM; Likhitkar, MS; Vedpathak, PR | 1 |
de Visscher, SA; Dijkstra, PU; Hopper, C; Karakullukcu, B; Melchers, LJ; Roodenburg, JL; Tan, IB; Witjes, MJ | 1 |
Bottini, G; Hopper, C; Lee, G; Story, W; Sultan, AA; Vaz, F | 1 |
Aans, JB; Hamming-Vrieze, O; Karakullukcu, B; Navran, A; Niatsetski, Y; Sterenborg, HJ; Tan, IB; Teertstra, HJ; van den Boom, F; van Veen, RL | 1 |
Amelink, A; de Bruijn, HS; de Visscher, SA; Robinson, DJ; Roodenburg, JL; Sterenborg, HJ; van der Ploeg-van den Heuvel, A; van der Vegt, B; Witjes, MJ | 1 |
Algharib, AM; Hopper, C; Parekh, J; Sultan, A; Vaz, F | 1 |
Béalle, G; Clément, O; Di Corato, R; Espinosa, A; Kolosnjaj-Tabi, J; Ménager, C; Silva, AK; Wilhelm, C | 1 |
Horlings, RK; Terra, JB; Witjes, MJ | 1 |
Bielawska, A; Bielawski, J; Boppana, NB; Delor, JS; Korbelik, M; Kraveka, JM; Li, LI; Pierce, JS; Rahmaniyan, M; Separovic, D; Zhang, K | 1 |
Carstens, MG; Flesch, FM; Helwig, C; Hennink, WE; Hofman, JW; van Nostrum, CF; van Zeeland, F | 1 |
Lorenz, KJ; Maier, H | 2 |
Bing Tan, I; Copper, MP; Karakullukcu, B; Klop, WM; van Oudenaarde, K; van Veen, R; Wildeman, M | 1 |
Ceruse, P; Dolivet, G; Rauschning, W; Roest, G; Tan, IB; Vander Poorten, V | 1 |
Bhatti, G; Bielawski, J; Korbelik, M; Merchant, S; Ogretmen, B; Pierce, JS; Separovic, D; Tarca, AL | 1 |
Hamdoon, Z; Hopper, C; Jerjes, W; Upile, T | 1 |
Korbelik, M; Separovic, D; Zhang, W | 2 |
de Visscher, SA; Dijkstra, PU; Roodenburg, JL; Tan, IB; Witjes, MJ | 1 |
Ballini, JP; Blant, SA; Glanzmann, TM; Monnier, P; van den Bergh, H; Wagnières, G | 1 |
Copper, MP; Oppelaar, H; Ruevekamp, MC; Stewart, FA; Tan, IB | 1 |
Banerjee, AS; Benjamin, E; Dilkes, MG; Ovaisi, S | 1 |
Biel, MA; D'Cruz, AK; Robinson, MH | 1 |
Hopper, C; Kübler, A; Lewis, H; Putnam, G; Tan, IB | 1 |
Buchholz, J; Kaser-Hotz, B; Khan, T; Melzer, K; Rohrer Bley, C; Roos, M; Schwendener, RA; Walt, H | 1 |
Buchholz, J; Kaser-Hotz, B; Laluhová, D; Ohlerth, S; Roos, M; Walt, H | 1 |
El-Maaytah, M; Hopper, C; Jerjes, W; Khalil, HS; Lewis, MP; Macrobert, AJ; Salih, V; Sharwani, A; Upile, T | 1 |
Baas, P; Out, R; Ruevekamp, M; Schellens, J; Stewart, FA; Triesscheijn, M; Van Berkel, TJ | 1 |
Andersson-Engels, S; Axelsson, J; Bendsoe, N; Gräfe, S; Johansson, A; Persson, L; Svanberg, K; Svanberg, S; Svensson, J; Trebst, T | 1 |
Naim, R | 1 |
Braichotte, D; Folli, S; Glanzmann, T; Monnier, P; Savary, JF; Van den Bergh, H; Wagnieres, G; Westermann, P | 1 |
Dilkes, MG; Kenyon, GS; Poate, TW | 1 |
Braichotte, DR; Monnier, P; Savary, JF; van den Bergh, HE | 1 |
Blant, SA; Fontolliet, C; Monnier, P; van den Bergh, H; Wagnières, G; Woodtli, A | 1 |
Andrejevic, S; Braichotte, D; Fontolliet, C; Monnier, P; Savary, JF; van den Bergh, H; Wagnières, G | 1 |
Braichotte, D; Fontolliet, C; Mizeret, J; Monnier, P; Savary, JF; van den Bergh, H; Wagnières, G | 1 |
Barberi-Heyob, M; Guillemin, F; Merlin, JL; Rezzoug, H | 1 |
Andrejevic-Blant, S; Ballini, JP; Fontolliet, C; Hadjur, C; Monnier, P; van den Bergh, H; Wagnières, G | 1 |
Fontolliet, C; Grosjean, P; Mizeret, J; Monnier, P; Savary, JF; Theumann, JF; Van den Bergh, H; Wagnieres, G; Woodtli, A | 1 |
Braichotte, D; Fontolliet, C; Grosjean, P; Monnier, P; Savary, JF; van den Bergh, H; Wagnieres, G | 1 |
Altermatt, HJ; Althaus, U; Krueger, T; Li, Q; Lim, CK; Reynolds, B; Ris, HB | 1 |
Altermatt, HJ; Im Hof, V; Mettler, D; Ris, HB; Stewart, CM | 1 |
Andrejevic-Blant, S; Fontolliet, C; Monnier, P; van den Bergh, H; Wagnieres, G; Woodtli, A | 1 |
Altermatt, HJ; Althaus, U; Giger, A; Krueger, T; Lim, CK; Ris, HB; Stewart, JC | 1 |
Kostron, H; Krimbacher, E; Marth, C; Zeimet, AG | 1 |
Haase, T; Kahle, B; Kübler, AC; Mühling, J; Rheinwald, M; Staff, C | 1 |
Ell, C; Gossner, L; May, A; Sroka, R | 1 |
Grosjean, P; Monnier, P; Radu, A; Zellweger, M | 1 |
Andrejevic Blant, S; Ballini, JP; Fontolliet, C; Monnier, P; van den Bergh, H; Wagnières, G | 1 |
Monnier, P; Radu, A; van den Bergh, H; Wagnières, G | 1 |
Chen, JY; Cheung, NH; Leung, AW; Mak, NK; Yow, CM | 1 |
Blant, SA; Braichotte, D; Forrer, M; Glanzmann, T; Grosjean, P; Monnier, P; van den Bergh, H; Wagnières, G; Woodtli, A | 1 |
Andrejevic Blant, S; Ballini, JP; Fontolliet, C; Grosjean, P; Monnier, P; van den Bergh, H; Wagnières, G | 1 |
Flechtenmacher, C; Kübler, AC; Reuther, T; Sinn, H; Zillmann, U | 1 |
de Carpentier, J; Hopper, C; Kübler, AC; Leonard, AG; Putnam, G | 1 |
Oppelaar, H; Snow, GB; Stigter, M; van Dongen, GA; Visser, GW; Vrouenraets, MB | 1 |
5 review(s) available for temoporfin and Carcinoma, Epidermoid
Article | Year |
---|---|
Photodynamic treatment outcomes of potentially-malignant lesions and malignancies of the head and neck region: A systematic review.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Chlorophyllides; Databases, Factual; Dihematoporphyrin Ether; Erythroplasia; Head and Neck Neoplasms; Hematoporphyrins; Humans; Hyperplasia; Indoles; Laser Therapy; Lasers; Leukoplakia; Leukoplakia, Oral; Mesoporphyrins; Oral Submucous Fibrosis; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Porphyrins; Squamous Cell Carcinoma of Head and Neck; Treatment Outcome | 2018 |
mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2015 |
mTHPC mediated photodynamic therapy (PDT) of squamous cell carcinoma in the head and neck: a systematic review.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Mesoporphyrins; Neoplasm Staging; Palliative Care; Photochemotherapy; Photosensitizing Agents; Quality of Life; Remission Induction | 2013 |
[Photodynamic therapy using m-THPC (Foscan). Treatment of head and neck squamous cell carcinoma].
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Clinical Trials as Topic; Head and Neck Neoplasms; Humans; Mesoporphyrins; Photochemotherapy; Treatment Outcome | 2008 |
Photodynamic therapy of early squamous cell cancers of the esophagus.
Topics: Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Squamous Cell; Dihematoporphyrin Ether; Drug Administration Routes; Esophageal Neoplasms; Esophagoscopy; Humans; Mesoporphyrins; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents | 2000 |
9 trial(s) available for temoporfin and Carcinoma, Epidermoid
Article | Year |
---|---|
mTHPC-mediated photodynamic therapy of early stage oral squamous cell carcinoma: a comparison to surgical treatment.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Oral Surgical Procedures; Photochemotherapy; Photosensitizing Agents; Prognosis; Retrospective Studies; Survival Rate | 2013 |
Temoporfin-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents | 2010 |
Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Humans; Lymphatic Metastasis; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Pharyngeal Neoplasms; Photochemotherapy; Photosensitizing Agents; Prospective Studies | 2003 |
mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Health Status; Humans; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pain; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Survival Analysis; Treatment Outcome | 2004 |
The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men.
Topics: Animals; Antineoplastic Agents; Apolipoproteins E; Area Under Curve; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Female; Half-Life; Head and Neck Neoplasms; Humans; Injections, Intravenous; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Mesoporphyrins; Mice; Mice, Inbred BALB C; Mice, Knockout; Neoplasms; Photochemotherapy; Photosensitizing Agents; Scavenger Receptors, Class B; Species Specificity; Tissue Distribution | 2007 |
[Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2008 |
Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths.
Topics: Aged; Animals; Carcinoma, Squamous Cell; Humans; Male; Mesoporphyrins; Mice; Mice, Nude; Middle Aged; Mouth Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Radiation-Sensitizing Agents; Spectrometry, Fluorescence | 1995 |
Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck.
Topics: Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Head and Neck Neoplasms; Humans; Laser Therapy; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prognosis; Prospective Studies; Radiation Dosage; Skin Neoplasms; Survival Rate; Treatment Outcome | 1999 |
Treatment of squamous cell carcinoma of the lip using Foscan-mediated photodynamic therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Injections, Intravenous; Laser Therapy; Lip Neoplasms; Lymphatic Metastasis; Male; Mesoporphyrins; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Photosensitivity Disorders; Photosensitizing Agents; Prospective Studies; Radiation Dosage; Remission Induction; Safety; Treatment Outcome | 2001 |
44 other study(ies) available for temoporfin and Carcinoma, Epidermoid
Article | Year |
---|---|
Non-metastatic cutaneous squamous cell carcinoma treated with photodynamic therapy using intravenous mTHPC.
Topics: Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Humans; Infusions, Intravenous; Lasers, Semiconductor; Male; Mesoporphyrins; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Remission Induction; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; Skin Neoplasms | 2019 |
Periorbital skin cancers subjected to mTHPC-photodynamic therapy: A prospective study.
Topics: Administration, Intravenous; Adult; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Male; Mesoporphyrins; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Skin Neoplasms; Treatment Outcome | 2020 |
Strategies of airway management for head and neck photo-dynamic therapy.
Topics: Airway Management; Airway Obstruction; Anti-Inflammatory Agents; Antineoplastic Agents; Carcinoma, Squamous Cell; Cricoid Cartilage; Dexamethasone; Female; Head and Neck Neoplasms; Humans; Intubation, Intratracheal; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Thyroid Cartilage; Tongue Neoplasms; Tracheostomy; Treatment Outcome | 2013 |
MR and CT based treatment planning for mTHPC mediated interstitial photodynamic therapy of head and neck cancer: description of the method.
Topics: Algorithms; Antineoplastic Agents; Carcinoma, Squamous Cell; Decision Support Techniques; Humans; Magnetic Resonance Imaging; Male; Mesoporphyrins; Middle Aged; Neoplasm Recurrence, Local; Patient Care Planning; Photochemotherapy; Photosensitizing Agents; Positron-Emission Tomography; Software; Tomography, X-Ray Computed; Tongue Neoplasms | 2013 |
Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.
Topics: 4-Nitroquinoline-1-oxide; Animals; Carcinogens; Carcinoma, Squamous Cell; Liposomes; Male; Mesoporphyrins; Microscopy, Confocal; Microscopy, Fluorescence; Mouth Mucosa; Mouth Neoplasms; Observer Variation; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Wistar | 2013 |
Endoluminal tracheal stenting prior to head and neck PDT.
Topics: Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Squamous Cell Carcinoma of Head and Neck; Stents; Tracheal Stenosis; Treatment Outcome | 2014 |
Combining magnetic hyperthermia and photodynamic therapy for tumor ablation with photoresponsive magnetic liposomes.
Topics: Ablation Techniques; Animals; Biological Transport; Carcinoma, Squamous Cell; Cell Death; Cell Line, Tumor; Combined Modality Therapy; Drug Liberation; Female; Humans; Hyperthermia, Induced; Liposomes; Magnets; Mesoporphyrins; Mice; Models, Molecular; Molecular Conformation; Nanomedicine; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Singlet Oxygen | 2015 |
Fumonisin B1 Inhibits Endoplasmic Reticulum Stress Associated-apoptosis After FoscanPDT Combined with C6-Pyridinium Ceramide or Fenretinide.
Topics: Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Caspase Inhibitors; Cell Line, Tumor; Ceramides; Combined Modality Therapy; Endoplasmic Reticulum Stress; Fenretinide; Fumonisins; Head and Neck Neoplasms; Humans; Mesoporphyrins; Photochemotherapy; Pyridinium Compounds; Radiation-Sensitizing Agents; Squamous Cell Carcinoma of Head and Neck | 2017 |
Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation.
Topics: Caproates; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Head and Neck Neoplasms; Humans; Lactones; Lipase; Liposomes; Mesoporphyrins; Micelles; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Technology, Pharmaceutical | 2008 |
Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients.
Topics: Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Disease-Free Survival; Female; Follow-Up Studies; Germany; Head and Neck Neoplasms; Humans; Injections, Intravenous; Magnetic Resonance Imaging; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Positron-Emission Tomography; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Disease-Free Survival; Humans; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Photochemotherapy; Photosensitizing Agents; Survival Rate | 2011 |
Enhanced tumor cures after Foscan photodynamic therapy combined with the ceramide analog LCL29. Evidence from mouse squamous cell carcinomas for sphingolipids as biomarkers of treatment response.
Topics: Animals; Biomarkers; Carcinoma, Squamous Cell; Ceramides; Disease Models, Animal; Female; Head and Neck Neoplasms; Mesoporphyrins; Mice; Mice, Inbred C3H; Photochemotherapy; Photosensitizing Agents; Pyridinium Compounds; Spectrometry, Mass, Electrospray Ionization; Sphingolipids; Treatment Outcome | 2011 |
Optical coherence tomography-guided photodynamic therapy for skin cancer: case study.
Topics: Carcinoma, Squamous Cell; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Tomography, Optical Coherence; Treatment Outcome | 2011 |
Amplification of cancer cell apoptosis in photodynamic therapy-treated tumors by adjuvant ceramide analog LCL29.
Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium; Carcinoma, Squamous Cell; Ceramides; Chemotherapy, Adjuvant; Flow Cytometry; Head and Neck Neoplasms; Macrophages; Mesoporphyrins; Mice; Mice, Inbred C3H; Mitochondria; Phagocytosis; Photochemotherapy; Photosensitizing Agents; Pyridinium Compounds | 2011 |
Monitoring ceramide and sphingosine-1-phosphate levels in cancer cells and macrophages from tumours treated by photodynamic therapy.
Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Ceramides; Head and Neck Neoplasms; Indoles; Lysophospholipids; Macrophages; Mesoporphyrins; Mice; Mice, Inbred C3H; Organosilicon Compounds; Photochemotherapy; Photosensitizing Agents; Pyridinium Compounds; Sphingosine | 2012 |
Uptake and localisation of mTHPC (Foscan) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study.
Topics: Animals; Carbon Isotopes; Carcinoma, Squamous Cell; Cricetinae; Drug Screening Assays, Antitumor; Female; Humans; Light; Mesocricetus; Mesoporphyrins; Mouth Neoplasms; Photochemotherapy; Photosensitizing Agents; Species Specificity; Spectrometry, Fluorescence; Tissue Distribution | 2002 |
Treatment of primary mucosal head and neck squamous cell carcinoma using photodynamic therapy: results after 25 treated cases.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Mesoporphyrins; Mouth Neoplasms; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Treatment Outcome | 2003 |
mTHPC-mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Injections, Intravenous; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Quality of Life; Treatment Outcome | 2004 |
Optimizing photodynamic therapy: in vivo pharmacokinetics of liposomal meta-(tetrahydroxyphenyl)chlorin in feline squamous cell carcinoma.
Topics: Animals; Area Under Curve; Biological Availability; Carcinoma, Squamous Cell; Cats; Injections, Intravenous; Liposomes; Mesoporphyrins; Metabolic Clearance Rate; Photochemotherapy; Photosensitizing Agents; Skin; Spectrometry, Fluorescence; Time Factors | 2005 |
Changes in vascularity and blood volume as a result of photodynamic therapy can be assessed with power Doppler ultrasonography.
Topics: Animals; Blood Volume; Carcinoma, Squamous Cell; Cats; Female; Image Processing, Computer-Assisted; Male; Mesoporphyrins; Neovascularization, Pathologic; Photochemotherapy; Photosensitizing Agents; Skin; Skin Neoplasms; Ultrasonography, Doppler | 2006 |
Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cells, Cultured; Down-Regulation; Humans; Keratinocytes; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mesoporphyrins; Mouth Neoplasms; Neoplasm Invasiveness; Photochemotherapy; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A | 2006 |
Fluorescence monitoring of a topically applied liposomal Temoporfin formulation and photodynamic therapy of nonpigmented skin malignancies.
Topics: Administration, Topical; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorescence; Humans; Liposomes; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2007 |
Use of photodynamic therapy for the treatment of squamous cell carcinoma of the soft palate.
Topics: Carcinoma, Squamous Cell; Female; Humans; Laser Therapy; Mesoporphyrins; Middle Aged; Palatal Neoplasms; Palate, Soft; Photochemotherapy; Photosensitizing Agents | 1996 |
Optimizing light dosimetry in photodynamic therapy of early stage carcinomas of the esophagus using fluorescence spectroscopy.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Esophageal Neoplasms; Humans; Mesoporphyrins; Photochemotherapy; Radiation-Sensitizing Agents; Radiometry; Spectrometry, Fluorescence; Triazenes | 1996 |
In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin.
Topics: Animals; Carcinoma, Squamous Cell; Cricetinae; Mesocricetus; Mesoporphyrins; Mouth Neoplasms; Neoplasms, Experimental; Photochemotherapy; Radiation-Sensitizing Agents | 1996 |
Measurements by fluorescence microscopy of the time-dependent distribution of meso-tetra-hydroxyphenylchlorin in healthy tissues and chemically induced "early" squamous cell carcinoma of the Syrian hamster cheek pouch.
Topics: Animals; Carcinoma, Squamous Cell; Cheek; Cricetinae; Esophagus; Male; Mesocricetus; Mesoporphyrins; Microscopy, Fluorescence; Mouth Mucosa; Radiation-Sensitizing Agents; Tissue Distribution | 1996 |
Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
Topics: Antineoplastic Agents; Biopsy; Bronchial Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms; Evaluation Studies as Topic; Female; Humans; Male; Mesoporphyrins; Microscopy, Fluorescence; Middle Aged; Mouth Neoplasms; Neoplasms, Second Primary; Photochemotherapy; Radiation-Sensitizing Agents | 1997 |
Sensitive isocratic liquid chromatographic assay for the determination of 5,10,15,20-tetra(m-hydroxyphenyl)chlorin in plasma and tissue with electrochemical detection.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Colonic Neoplasms; Electrochemistry; Female; Humans; Mesoporphyrins; Mice; Mice, Nude; Photosensitizing Agents; Reproducibility of Results; Sensitivity and Specificity | 1997 |
Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Cheek; Cricetinae; Drug Administration Schedule; Light; Mesocricetus; Mesoporphyrins; Microscopy, Fluorescence; Mouth Neoplasms; Photochemotherapy; Radiation-Sensitizing Agents; Tissue Distribution | 1997 |
Photodynamic therapy for cancer of the upper aerodigestive tract using tetra(m-hydroxyphenyl)chlorin.
Topics: Adult; Aged; Antineoplastic Agents; Argon; Bronchial Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms; Evaluation Studies as Topic; Female; Humans; Laser Therapy; Male; Mesoporphyrins; Middle Aged; Neoplasm Recurrence, Local; Outcome Assessment, Health Care; Photochemotherapy; Photosensitizing Agents; Tongue Neoplasms | 1996 |
Photodynamic therapy of early squamous cell carcinomas of the esophagus: a review of 31 cases.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Dihematoporphyrin Ether; Esophageal Neoplasms; Esophagus; Female; Hematoporphyrin Derivative; Hematoporphyrin Photoradiation; Humans; Male; Mesoporphyrins; Middle Aged; Necrosis; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Photosensitizing Agents; Precancerous Conditions; Treatment Outcome | 1998 |
Photosensitizing effects of m-tetrahydroxyphenylchlorin on human tumor xenografts: correlation with sensitizer uptake, tumor doubling time and tumor histology.
Topics: Adenocarcinoma; Animals; Carcinoma, Squamous Cell; Female; Humans; Mesoporphyrins; Mesothelioma; Mice; Mice, Nude; Necrosis; Neoplasm Transplantation; Neoplasms, Experimental; Photochemotherapy; Photosensitizing Agents; Transplantation, Heterologous | 1998 |
Endobronchial photodynamic therapy: comparison of mTHPC and polyethylene glycol-derived mTHPC on human tumor xenografts and tumor-free bronchi of minipigs.
Topics: Adenocarcinoma; Animals; Bronchi; Bronchial Neoplasms; Carcinoma, Squamous Cell; Humans; Mesoporphyrins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Swine; Swine, Miniature; Transplantation, Heterologous | 1998 |
Interstitial photodynamic therapy with tetra(m-hydroxyphenyl)chlorin: tumor versus striated muscle damage.
Topics: Animals; Carcinoma, Squamous Cell; Cricetinae; Male; Mesocricetus; Mesoporphyrins; Microscopy, Fluorescence; Muscle, Skeletal; Necrosis; Photochemotherapy; Photosensitizing Agents; Time Factors | 1998 |
Photodynamic therapy with mTHPC and polyethylene glycol-derived mTHPC: a comparative study on human tumour xenografts.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Dermatitis, Phototoxic; Humans; Mesoporphyrins; Mesothelioma; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Photochemotherapy; Polyethylene Glycols; Radiation-Sensitizing Agents; Transplantation, Heterologous | 1999 |
Photodynamic therapy for recurrent gynecologic malignancy: a report on 4 cases.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Disease Progression; Female; Genital Neoplasms, Female; Humans; Lung Neoplasms; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Remission Induction; Survival Rate; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 1999 |
A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia.
Topics: Adenocarcinoma; Aged; Aminolevulinic Acid; Barrett Esophagus; Biopsy; Carcinoma, Squamous Cell; Cardia; Catheterization; Drug Therapy, Combination; Endoscopy, Digestive System; Endosonography; Equipment Design; Esophageal Neoplasms; Female; Fiber Optic Technology; Follow-Up Studies; Humans; Male; Mesoporphyrins; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Tomography, X-Ray Computed; Treatment Outcome | 1999 |
Pulse oximeter as a cause of skin burn during photodynamic therapy.
Topics: Burns; Carcinoma in Situ; Carcinoma, Squamous Cell; Esophageal Neoplasms; Female; Finger Injuries; Humans; Mesoporphyrins; Middle Aged; Nails; Oximetry; Photochemotherapy; Photosensitizing Agents | 1999 |
Time-dependent biodistribution of tetra(m-hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study.
Topics: Animals; Carcinoma, Squamous Cell; Cricetinae; Mesocricetus; Mesoporphyrins; Microscopy, Fluorescence; Photochemotherapy; Photosensitizing Agents; Porphyrins; Tissue Distribution | 2000 |
Cellular uptake, subcellular localization and photodamaging effect of temoporfin (mTHPC) in nasopharyngeal carcinoma cells: comparison with hematoporphyrin derivative.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cytoplasm; Flow Cytometry; Hematoporphyrins; Humans; Male; Mesoporphyrins; Microscopy, Confocal; Mitochondria; Nasopharyngeal Neoplasms; Photochemotherapy; Photosensitizing Agents; Spectrophotometry; Tumor Cells, Cultured | 2000 |
Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements.
Topics: Animals; Carcinoma, Squamous Cell; Cricetinae; Drug Screening Assays, Antitumor; Humans; Light; Mesocricetus; Mesoporphyrins; Mouth Mucosa; Neoplasms; Photochemotherapy; Photosensitizing Agents; Species Specificity; Tissue Distribution | 2000 |
Localization of tetra(m-hydroxyphenyl)chlorin (Foscan) in human healthy tissues and squamous cell carcinomas of the upper aero-digestive tract, the esophagus and the bronchi: a fluorescence microscopy study.
Topics: Aged; Bronchi; Carcinoma, Squamous Cell; Esophagus; Female; Head and Neck Neoplasms; Humans; Male; Mesoporphyrins; Microscopy, Fluorescence; Middle Aged; Mouth Mucosa; Photochemotherapy; Photosensitizing Agents; Time Factors | 2001 |
Comparison of the in vivo efficiency of photofrin II-, mTHPC-, mTHPC-PEG- and mTHPCnPEG-mediated PDT in a human xenografted head and neck carcinoma.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Dermatitis, Phototoxic; Dihematoporphyrin Ether; Disease Models, Animal; Excipients; Female; Head and Neck Neoplasms; Humans; Mesoporphyrins; Mice; Middle Aged; Photochemotherapy; Polyethylene Glycols; Radiation-Sensitizing Agents; Random Allocation; Transplantation, Heterologous; Treatment Outcome; Tumor Cells, Cultured | 2001 |
Comparison of aluminium (III) phthalocyanine tetrasulfonate- and meta-tetrahydroxyphenylchlorin-monoclonal antibody conjugates for their efficacy in photodynamic therapy in vitro.
Topics: Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Division; Head and Neck Neoplasms; Humans; Immunoconjugates; Indoles; Mesoporphyrins; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Tumor Cells, Cultured | 2002 |